Jefferies Group restated their hold rating on shares of Clorox (NYSE:CLX) in a research report report published on Wednesday morning. Jefferies Group currently has a $130.00 target price on the stock.

Several other research analysts have also recently issued reports on the stock. Wells Fargo & Company restated a hold rating and issued a $130.00 target price on shares of Clorox in a report on Wednesday. Deutsche Bank assumed coverage on shares of Clorox in a report on Wednesday. They issued a hold rating and a $142.00 target price on the stock. Consumer Edge upgraded shares of Clorox from a neutral rating to an outperform rating in a report on Friday, November 10th. Zacks Investment Research upgraded shares of Clorox from a sell rating to a hold rating in a report on Monday, November 6th. Finally, Morgan Stanley cut their target price on shares of Clorox from $138.00 to $128.00 and set an equal weight rating on the stock in a report on Thursday, November 2nd. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average target price of $129.05.

Clorox (NYSE CLX) opened at $147.63 on Wednesday. The company has a quick ratio of 0.77, a current ratio of 1.10 and a debt-to-equity ratio of 3.02. Clorox has a fifty-two week low of $117.94 and a fifty-two week high of $148.23. The stock has a market cap of $18,858.56, a P/E ratio of 26.35, a PEG ratio of 3.98 and a beta of 0.43.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.05. Clorox had a net margin of 11.84% and a return on equity of 161.59%. The firm had revenue of $1.50 billion for the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter last year, the business earned $1.36 earnings per share. The business’s revenue was up 4.0% on a year-over-year basis. research analysts forecast that Clorox will post 5.6 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox’s payout ratio is 61.88%.

In related news, SVP Michael R. Costello sold 10,574 shares of the firm’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the sale, the senior vice president now owns 34,867 shares of the company’s stock, valued at $4,742,260.67. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Matthew T. Laszlo sold 20,051 shares of the firm’s stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the sale, the senior vice president now directly owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The disclosure for this sale can be found here. Company insiders own 1.00% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. Parametric Portfolio Associates LLC lifted its position in Clorox by 3.9% during the third quarter. Parametric Portfolio Associates LLC now owns 536,640 shares of the company’s stock valued at $70,788,000 after buying an additional 20,303 shares during the period. Steward Partners Investment Advisory LLC purchased a new position in Clorox during the third quarter valued at $561,000. Smith Shellnut Wilson LLC ADV lifted its position in Clorox by 82.3% during the third quarter. Smith Shellnut Wilson LLC ADV now owns 4,042 shares of the company’s stock valued at $533,000 after buying an additional 1,825 shares during the period. Archford Capital Strategies LLC lifted its position in Clorox by 14.0% during the third quarter. Archford Capital Strategies LLC now owns 8,121 shares of the company’s stock valued at $1,071,000 after buying an additional 997 shares during the period. Finally, Moors & Cabot Inc. lifted its position in Clorox by 35.2% during the third quarter. Moors & Cabot Inc. now owns 3,456 shares of the company’s stock valued at $452,000 after buying an additional 899 shares during the period. 73.42% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This story was posted by Watch List News and is owned by of Watch List News. If you are viewing this story on another publication, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The correct version of this story can be viewed at https://www.watchlistnews.com/cloroxs-clx-hold-rating-reiterated-at-jefferies-group/1767585.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.